AKT1 and schizophrenia: Notably, antipsychotic treatments significantly increased AKT1 and GSK-3 phosphorylation in the rodent brain [216,217], possibly indicating that antipsychotics may revert the putative alterations in these two molecules in schizophrenia patients.